Anesthesia and analgesia
-
Anesthesia and analgesia · Feb 2000
The mechanical properties of intact and traumatized epidural catheters.
Comparative data on the mechanical properties of epidural catheters used clinically are not available. We performed a controlled laboratory investigation to assess the mechanical performance of three different intact or traumatized catheter types (Polyurethane, clear nylon, and radiopaque nylon catheters, designed for 18-gauge Tuohy needles). We studied a control (intact) and two trauma groups (needle bevel and surgical blade). Catheters were loaded to their breaking points by using a Lloyd LS500 material testing machine (Lloyd, Southampton, UK). Maximal load and extension values before breakage were measured, and modulus of elasticity and toughness values were calculated. Intact polyurethane catheters did not break within the limits of the experimental study (extension up to 3 times the original length of a specimen). The toughness values obtained from polyurethane and clear nylon catheters were significantly higher than those for the radiopaque catheters in intact specimens (P < 0.05). In the traumatized groups, polyurethane catheters had the highest toughness values (P < 0.05). Modulus of elasticity values were higher in both control and trauma groups of the radiopaque catheters when compared with the polyurethane and clear nylon catheters, which indicates a higher stiffness to elastic deformation (P < 0.05). In conclusion, polyurethane catheters are the most durable catheter type to tensile loading, either intact or traumatized. Mechanical properties can be used to predict complications related to the clinical use of these catheters. ⋯ Using a computer-assisted material testing machine, we studied the mechanical properties of three different types of epidural catheters, either intact or traumatized, in a blinded, controlled study. This information may be vital to clinicians who implant epidural catheters by helping them choose a catheter that has the lowest probability of failure.
-
Anesthesia and analgesia · Feb 2000
Randomized Controlled Trial Clinical TrialSmall-dose dopamine increases epidural lidocaine requirements during peripheral vascular surgery in elderly patients.
We studied 20 patients over the age of 65 yr undergoing prolonged peripheral vascular surgery under continuous lidocaine epidural anesthesia, anticipating that the increased hepatic metabolism caused by small-dose IV dopamine would lower plasma lidocaine concentrations. Subjects were assigned (random, double-blinded) to receive either a placebo IV infusion or dopamine, 2 microg. kg(-1). min(-1) during and for 5 h after surgery. Five minutes after the IV infusion was started, 20 mL of 2% lidocaine was injected through the epidural catheter. One-half hour later, a continuous epidural infusion of 2% lidocaine at 10 mL/h was begun. The epidural infusion was temporarily decreased to 5 mL/h or 5 mL boluses were added to maintain a T8 analgesic level. Arterial blood samples were analyzed for plasma lidocaine concentrations regularly during and for 5 h after surgery. Plasma lidocaine concentrations increased continuously during the epidural infusion and, despite wide individual variation, were similar for the two groups throughout the observation period. During the observation period, the mean maximal plasma lidocaine concentration was 5.8 +/- 2.3 microg/mL in the control group and 5.7 +/- 1.2 microg/mL in the dopamine group. However, the mean hourly lidocaine requirement during surgery was significantly different, 242 +/- 72 mg/h for control and 312 +/- 60 mg/h for dopamine patients (P < 0.03). At the end of Hour 4, the last period when all 20 patients were still receiving the epidural lidocaine infusion, the total lidocaine requirement was significantly different, 1088 +/- 191 mg for the control group and 1228 +/- 168 mg for the dopamine group (P < 0.05). Despite very large total doses of epidural lidocaine (1650 +/- 740 mg, control patients, and 1940 +/- 400, dopamine patients) mean maximal plasma concentrations remained below 6 microg/mL, and no patient exhibited signs or symptoms of toxicity. We conclude that small-dose IV dopamine increased epidural lidocaine requirements, presumably as a consequence of increased metabolism. ⋯ We tested dopamine, a drug that increases liver metabolism of the local anesthetic lidocaine to determine if it would prevent excessively large amounts of lidocaine in the blood during prolonged epidural anesthesia in elderly patients. Dopamine did not alter the blood levels of lidocaine, but it did increase the lidocaine dose requirement to maintain adequate epidural anesthesia.
-
Anesthesia and analgesia · Feb 2000
Randomized Controlled Trial Clinical TrialSufentanil does not prolong the duration of analgesia in a mepivacaine brachial plexus block: a dose response study.
To date, results of studies evaluating the efficacy of opioids and local anesthetic combinations in the brachial plexus are inconclusive. We examined whether increasing sufentanil in doses of 5, 10, and 20 microg decreased onset time or increased duration of an axillary brachial plexus block. Ninety-two patients scheduled for carpal tunnel release under axillary brachial plexus block were enrolled in the study. Patients were randomized to receive axillary plexus block with 40 mL 1.5% mepivacaine and saline (Group 1), sufentanil 5 microg (Group 2), 10 microg (Group 3), or 20 microg (Group 4). Onset and duration of sensory and motor block were measured. Opioid-related side effects were recorded. The addition of sufentanil did not improve speed of onset or increase the duration of sensory or motor block. Paradoxically, duration of sensory and motor block was longest in the control group: sensory, 241 min (188-284) and motor, 234 min (128-305), and decreased with increasing doses of sufentanil in Group 4: sensory, 216 min (115-315) and motor, 172 min (115-260) (P < 0.05). Side effects occurred in 55% of patients belonging to Groups 2 and 4, and in 60% of the patients in Group 3. In contrast, only 10% of the patients reported side effects in the control group. We conclude that sufentanil added to mepivacaine does not increase the onset or prolong the duration of an axillary plexus block. Furthermore, the addition of sufentanil was associated with a frequent incidence of side effects. ⋯ This study demonstrates that the addition of sufentanil in a dose-dependent manner to 1.5% mepivacaine in the axillary plexus does not improve onset or duration of blockade, and that this admixture is associated with an increased incidence of side effects.